PUBLISHER: Mordor Intelligence | PRODUCT CODE: 2118060
PUBLISHER: Mordor Intelligence | PRODUCT CODE: 2118060
According to Mordor Intelligence, the medical devices machine tools market size is projected to be USD 3.11 billion in 2025, USD 3.36 billion in 2026, and reach USD 4.82 billion by 2031, growing at a CAGR of 7.48% from 2026 to 2031.

This report is Segmented by Machine Type (CNC Turning Machines, CNC Machining Centers, and More), by Application (Surgical and Robotic Instruments, Orthopedic and Trauma Devices, and More), by End-User (Medical Device OEMs, and More), and by Geography (North America, Asia-Pacific, Europe, and More). The Report Offers Market Size and Forecasts in Value (USD) for all the Above Segments.
Patient-specific hip stems, tibial trays, and spinal fusion cages require complex machining and tightly controlled surfaces. Five-axis milling reduces the need to reposition workpieces during production. Fewer setups can reduce the number of records that manufacturers must validate under ISO 13485 requirements. This supports demand for CNC platforms with in-process metrology, tool wear compensation, and process traceability in the medical devices machine tools market. Makino's N2-5XA uses a dry-chip-less design intended to address contamination control in implant production. Machine specifications are therefore increasingly shaped by cleanliness and documentation needs as well as geometric capability.
The QMSR Final Rule became effective on February 2, 2026, and aligned 21 CFR Part 820 with ISO 13485:2016. Medical device manufacturers now need stronger documentation, risk management, and traceability across production steps.Buyers of new equipment need installation, operational, and processing qualification documents that fit these requirements. Existing facilities that used legacy Quality System Regulation procedures may need to revalidate machines or replace them. Suppliers with dedicated medical compliance support can reduce the implementation burden on buyers. This increases the value of validation-ready equipment in the medical devices machine tools market.
New CNC cells must undergo qualification before they can produce regulated medical components. Factory acceptance testing, coolant validation, cleanroom installation, and manufacturing execution system integration can lengthen the deployment process. Software updates, major modifications, and process changes can also trigger partial or full requalification. Class III implant and patient-contact component manufacturers must maintain capable processes on critical features, which limits the range of equipment suitable for some programs. These requirements can concentrate demand at the premium end of the medical device machine tool market. They can also delay the ramp-up of new production lines even when manufacturers have demand for additional capacity.
Other drivers and restraints analyzed in the detailed report include:
For complete list of drivers and restraints, kindly check the Table Of Contents.
CNC machining centers held 28.5% of the 2025 medical device machine tool market. Their position reflects their use in high-volume implant and instrument production, where complex geometry and documented processes are both required. Five-axis centers support contoured surfaces and simultaneous machining on orthopedic and spinal parts. Laser cutting and micromachining machines are forecast to grow at an 8.8% CAGR from 2026 to 2031. These systems serve stent cutting, device marking, and ablation work on components that can be damaged by conventional cutting. TRUMPF introduced the TruMicro 9010 in June 2025 for high-productivity ultra-short pulse processing of larger surfaces.
CNC turning machines play a substantial role in the production of bone screws, cannulated fasteners, and shafts. Swiss-type and turn-mill configurations can produce high volumes of titanium and stainless-steel parts with close concentricity. CNC grinding and finishing machines support implant surface preparation and other applications that need fine surface finishes. EDM remains necessary for hardened tooling and microfeatures that are difficult to produce by milling without burrs. Other systems, including ultrasonic, broaching, and drilling machines, handle specialized work for PEEK implants and catheter tooling. Each of these technologies serves a different production need in the medical device machine tools market. Laser parameter qualification is especially important because process settings must be documented and controlled under the QMSR framework.
North America held 31.6% of the medical devices machine tools market size in 2025 and is forecast to grow at an 8.9% CAGR through 2031. The region benefits from QMSR-driven qualification work at OEM and contract manufacturing facilities. Near-shoring also supports investment in the United States, Canadian, and Costa Rica. Aging populations continue to support orthopedic and cardiovascular device volumes. This combination links compliance spending with demand for additional qualified capacity. Freudenberg Medical expanded its Costa Rica operations in 2025 to produce electrophysiology and structural heart catheters.
Europe remains a major demand base, supported by Germany's machine tool ecosystem and medical technology production. Germany's medical technology sector generated EUR 41.4 billion (USD 46.63 billion) in 2024, equivalent to USD 45 billion (USD 50.79 billion), and had an export ratio of 68%. VDW reported that German machine tool production fell 8% in 2025, while medical technology provided demand support alongside defense, aerospace, and electronics. Switzerland, Ireland, and the United Kingdom add to the regional production base. European buyers must also consider cybersecurity requirements for networked machinery under the EU Machinery Regulation. These factors support replacement and capability investments in the medical devices machine tools market.
Asia-Pacific is the main growth area outside North America, with Japan, South Korea, China, Malaysia, Thailand, and India providing manufacturing capacity. Japan's machine tool orders reached JPY 1.6 trillion (USD 10.6 billion) in 2025, and the Japan Machine Tool Builders' Association expected JPY 1.7 trillion (USD 11.36 billion) in orders for 2026. Japan's automation base supports demand across medical, semiconductor, and defense applications. FANUC reported JPY 857.8 billion (USD 5.73 billion) in fiscal 2025 revenue and announced a USD 90 million investment in North American robot production capacity in April 2026.South America, the Middle East, and Africa remain smaller medical machining markets. Costa Rica has become an important location for precision manufacturing due to its proximity to North American OEMs and its growing pool of qualified contract manufacturers.